# Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease

> **NCT03666351** · PHASE4 · COMPLETED · sponsor: **Hanmi Pharmaceutical Company Limited** · enrollment: 128 (actual)

## Conditions studied

- Aortic Stenosis
- Aortic Regurgitation
- Hypertension
- LVM
- Left Ventricular Hypertrophy

## Interventions

- **DRUG:** Amlodipine 5mg
- **DRUG:** Losartan
- **DRUG:** Losartan and Amlodipine
- **DRUG:** Amlodipine/Losartan/Chlorthalidone
- **DRUG:** current treatment

## Key facts

- **NCT ID:** NCT03666351
- **Lead sponsor:** Hanmi Pharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-18
- **Primary completion:** 2022-07-25
- **Final completion:** 2022-07-25
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2022-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03666351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03666351, "Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03666351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*